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Aim:  To determine whether HIV-positive patients have a longer time to healing, 
more complications and poorer functional outcomes after Obstetric Anal Sphincter 
Injury (OASI) than an HIV-negative control group. 
Setting: Mowbray Maternity, New Somerset and Groote Schuur Hospitals of the 
Western Cape Peninsula Maternal and Neonatal Service. 
Methods: Prospective cohort in two parts. Assessment of all patients with OASI
between September 2008 and July 2009. Initial documentation, (post sphincter repair)
before discharge from hospital; of demographics, details of repair, and pre-pregnancy
anal, urinary and sexual function, as well as pre-pregnancy perineal pain. Six week 
postpartum follow-up of anal and urinary continence, sexual function and perineal 
pain, as well as a clinical examination.
Results: Sixty-eight women were enrolled including 54 who were HIV-negative and 
14 who were HIV-positive. Thirty-six women attended follow-up; 28 HIV-negative
and 8 HIV-positive. HIV-positive women were significantly more likely to experience
pre-pregnancy urgency (50.0% vs 14.8%, p=0.0094). HIV-positive women were
significantly more likely to experience solid stool incontinence (mean Wexner Score
0.9 vs 0.1; p=0.041) and have a negative lifestyle impact (mean Wexner Score 0.9 vs 
0.1; p=0.007), as well as experiencing more postpartum stress urinary incontinence
(incidence 37.5% vs 0%; p=0.0078) than their HIV-negative counterparts at six-
weeks postpartum. There were no significant differences in healing, infection, anal 
sphincter integrity or tone, between the two groups.  
Conclusion: HIV-positive patients experience significantly more solid stool 
incontinence and have poorer lifestyle impact scores after OASI at six weeks 
postpartum. They also experience more pre-pregnancy urgency and postpartum stress 
urinary incontinence than HIV-negative controls. HIV-positive women also have 
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Obstetric Anal Sphincter Injury (OASI) is potentially one of the most debilitating 
complications associated with vaginal delivery. For a young woman with a newborn 
baby, this unfortunate event, with its potential consequence of anal incontinence, can 
have a devastating impact on her health physically, psychologically and socially.  
 
Obstetric services in Cape Town, as in many parts of South Africa, have become 
increasingly stretched, and associated with this staff are having to manage a 
significant number of complications. Adding to this, the Human Immuno-deficiency 
Virus (HIV) pandemic in South Africa is increasing in our population. The question 
naturally arises regarding the interplay between OASI and HIV infection. Since we 
work in a population where there is a high prevalence of HIV, probably amongst the 
largest in the world, we felt we were in an ideal situation to compare the outcomes of 
OASI in HIV-positive and HIV-negative patients. 
 
 
1.2 HIV Infection 
 
1.2.1 Incidence of HIV Infection 
 
The exact prevalence and incidence of HIV in the South African population has been 
difficult to ascertain due to the fact that HIV is not a notifiable illness. Some of the 
best data we have are prevalence studies performed by the Department of Health 
amongst women attending antenatal clinics. The South African Department of Health 
Study 2006 reported a national HIV prevalence of 29.1% amongst 33 033 women 
attending antenatal clinics across the country. The highest prevalence was reported in 
women aged 25-29 years.  The prevalence of HIV-positive women in Western Cape 
antenatal clinics in 2006 was 15.2%. All women in this study were pregnant and thus 
had engaged in unprotected sexual intercourse, which may have overestimated the 














The South African National HIV Survey estimated that 10.8% of all South Africans 
over the age of two years were living with HIV in 2005. The prevalence amongst 
South African women was reported to be 13.3%. Interestingly, the survey reported 
that only 1.9% of women in the Western Cape were HIV-positive. This is 
significantly lower than the prevalence rates from the antenatal clinic data, and could 
be due to the small sample size of the study, and the fact that only 55% of eligible 
people consented to participate. This study also included men, children and non-
sexually active women. 
 
The Actuarial Society of South Africa (ASSA 2003) describes a prevalence rate of 5.2 
million HIV-positive South Africans in 2003, with a further projection of 5.8 million 
South Africans being HIV-positive by 2010. They also estimate a rate of 500 000 new 




1.3 Obstetric Anal Sphincter Injury (OASI) 
 
1.3.1 Incidence of OASI and Risk Factors  
 
The incidence of OASI following vaginal delivery ranges from 0.6-2.4% (Fornell et al 
1996; Sultan et al, 1994; Walsh et al, 1996).  Established risk factors associated with 
this injury include birth weight >4kg, primiparity, persistent occipitoposterior 
position, induction of labour, epidural, prolonged second stage of labour, shoulder 
dystocia, midline episiotomy and forceps delivery (Rieger et al, 2004; Sultan et al, 
1994; Wood et al, 1998; RCOG 2007).     
 
1.3.2 Classification of Perineal Injury 
 
Perineal injuries sustained at vaginal delivery are classified as first, second, third or 
fourth degree tears. A third degree tear, by consensus, refers to a disruption of the 
muscles comprising the anal sphincter, while a fourth degree tear refers to disruption 
of the anal sphincter as well as the rectal mucosa (RCOG, 2007). Both third and 














perineal muscles. The rectal mucosa is seldom disrupted in the absence of anal 
sphincter injury. Hence for the purpose of this study, OASI will refer to third and/or 
fourth degree tears. 
 
Anatomically, the anal sphincter comprises the external anal sphincter (EAS) and the 
internal anal sphincter (IAS). Third degree tears can be complete or partial, and are 
further subdivided into 3a, 3b and 3c tears. 3a tears involve <50% of the EAS, in 3b 
tears >50% of the EAS is disrupted and 3c tears involve the IAS as well as the EAS. 
 
1.3.3 Pathophysiology of incontinence after OASI 
 
Anal continence depends on an anatomically intact anal sphincter, as well as normal 
innervation of the sphincter muscles. The external component of the anal sphincter 
comprises striated muscle which is under voluntary control, supplied by the pudendal 
nerve (S2,3,4). The internal anal sphincter is the thickened continuation of the smooth 
muscle encircling the rectum. This muscle is under autonomic nervous system 
control.  Vaginal delivery will potentially damage this mechanism either by partial or 
complete anatomical disruption of the sphincter mechanism, or damage to the 
pudendal nerve. Pudendal nerve terminal motor latency (PNTML) tests measure the 
time delay between an electrical stimulus applied to the pudendal nerve and resultant 
muscle contraction. Studies looking at these tests have not shown significant 
differences between control and OASI groups, implying that varying continence 
between the two groups is due to anatomical disruption, and not nerve injury (Sultan 
et al, 1994). This highlights the importance of a good anatomical repair of disrupted 
sphincters in maintaining continence. 
 
1.3.4 Postpartum Repair Techniques and Outcomes 
 
Repair of OASI, in our clinical setting, involves immediate suturing under regional or 
general anaesthesia in theatre, using either an end-to-end (approximation) or overlap 
technique, by a registrar or consultant.  Post-operatively, antibiotic prophylaxis and 
stool softeners are administered to our patients. This practice is in keeping with 















Traditionally, the end-to-end technique was used by obstetricians in the primary repair 
of OASIs. Unfortunately, rates of incontinence following primary end-to-end repair 
have been shown to be as high as 40-61% (Pinta et al, 2004; Poen et al, 1998; Sultan 
et al, 1994), with the lowest documented rates being 7-25% (Mackenzie et al, 2004; 
Walsh et al, 1996; Wood et al, 1998).  These figures, along with evidence of even 
further deterioration in anal function over time (Fornell et al, 2005), are alarmingly 
high.  The common practice of colorectal surgeons to use an overlap technique for 
secondary repair of patients with anal incontinence, and the apparent inadequacy of 
approximation repair in terms of continence outcomes, prompted Sultan et al (1999) 
to be the first to objectively study the feasibility and outcome of the overlap technique 
as the primary method of anal sphincter repair (Sultan et al, 1994; Sultan et al 1999). 
The technique involved separate end-to-end repair of the IAS, (if it was identified as 
being disrupted), with an overlap repair of the EAS. Results of the study showed that 
overlap was “not only possible but appears to result in a better outcome than the 
conventional end-to-end approximation” (Sultan et al, 1999:322). Only two of the 27 
women reported symptoms of anal incontinence (8%), and that being for flatus only.  
 
Since that small pilot study there have been several randomized controlled trials 
(RCTs) comparing overlap to end-to-end repair. Fitzpatrick et al (2000) demonstrated 
no significant differences between the two groups in terms of faecal incontinence, 
anal manometry and endoanal ultrasonography at three months postpartum.  Garcia et 
al (2005), in a study that was probably underpowered due to poor follow-up rates, also 
demonstrated no difference in outcomes between the two techniques at three months 
post primary repair. The only RCT of overlap and end-to-end repair that followed 
patients up for 12 months was performed by Fernando et al (2006). This study showed 
the overlap group to have significantly lower rates of faecal incontinence, faecal 
urgency and perineal pain at 12 months. There was, however, no significant 
difference in dyspareunia and quality of life between the two groups. Of note is that in 
this study, repair was done by clinicians specifically trained in both techniques. 
 
A Cochrane review by Fernando et al (2006) found that the overlap technique was 
associated with a significantly lower incidence of faecal urgency and lower anal 
incontinence scores at 12 months post repair, as well as significantly less deterioration 














perineal pain, dyspareunia, flatal incontinence and faecal incontinence at 12 months. 
This review did not, however, recommend the overlap in preference to the end-to-end 
repair, on the grounds that the experience of the surgeon was not addressed in the 
studies reviewed.   
 
In 2007, Molander et al published a retrospective study of 42 women sustaining OASI 
where repair was with the overlap technique. At a mean of 9.4 months of follow-up, 
64% of the patients were completely asymptomatic for anal incontinence. 
In 2008, Lepistö et al recommended that the overlap technique be employed as the 
primary repair technique following a prospective case-control study with a 
retrospective end-to-end control group. Their findings included significantly better 
Wexner scores at six to nine months postpartum in the overlap group. 
 
Despite best obstetric practice, damage to the anal sphincter will remain a 
complication of vaginal delivery. The best functional outcome depends on a good 
anatomical repair, and normal innervation. The obstetrician can only do their best to 
modify the former, to optimise functional outcomes. In this regard, the evidence 
would suggest a move toward using the overlap technique of repair. International 
standards still include using either technique, however. 
 
 
1.4 Healing  
 
Good functional outcomes for any surgical technique rely on an absence of 
complications and optimal healing of the wound. Any interference with wound 
healing will impair outcome despite meticulous surgical technique. A dehisced anal 
sphincter repair will have significantly poorer function than an intact sphincter.  
 
Factors impacting negatively on the healing of any wound can be classified as local or 
general. Local factors include infection, a poor blood supply, excessive movement 
and the presence of foreign bodies. General factors include chronic disease, excess 
adrenocorticoids and deficiencies of vitamin C, zinc and amino acids (Govan, 














smoking have been shown to be significant risk factors in the dehiscence of 
episiotomies (Snyder et al, 1990).  
 
1.4.1 Infections and Wound Healing 
 
Williams and Chames (2006) studied the risk factors for perineal wound breakdown 
in 59 women.  They found that mediolateral episiotomy, operative vaginal delivery, 
higher order lacerations (ie third and fourth degree) and meconium-stained amniotic 
fluid led to an increase in wound dehiscence. There was an association with infection 
in 40.7% of cases. This finding is in keeping with the study by Ramin et al (1992), 
who also found infection to be associated with 79% of episiotomy dehiscences.  
Norderval et al (2005) also noted that wound infection complicated 7% of OASIs and 
that these women had significantly poorer functional outcomes as a result.  
 
Williams and Chames (2006) did not describe any association between pre-existing 
medical conditions and repair breakdown or infection. There is no mention of the 
prevalence of HIV in their study population.  Breakdown of perineal laceration repair 
was associated with significant morbidity and the need for additional medical care 
including longer hospital stays, more out-patient visits, additional theatre time and 
increased anaesthetic and antibiotic requirements.  
 
1.4.2 HIV and Wound Infections 
 
HIV causes immunodeficiency by infecting cells with the CD4 surface receptor. The 
largest population of cells with this receptor are the T-helper lymphocytes. Other cells 
with the receptor include macrophages, monocytes and central nervous system 
dendritic cells.  Following infection, variable lengths of clinical latency follow, with a 
steady destruction of CD4 T-lymphocytes. In this way, immunity is impaired, 
resulting in increased susceptibility to infection (Kumar & Clark, 1998; Gladwin & 
Trattler, 1999).  
 
A number of authors have reported on the impact of HIV on wound healing. An 
anecdotal report by Bayley (1990) suggested HIV infection to be more frequently 














abdominal wound sepsis following gynaecological surgery to be significantly higher 
in HIV-positive individuals (Jjuuko & Moodley, 2002). Local sepsis after 
haemorrhoidectomy has been shown to be significantly higher in patients with AIDS 
compared to controls and HIV-positive patients without clinical AIDS (Morandi et al, 
1999). In Malawi, studies showed wound sepsis to be increased in HIV-positive 
patients with compound tibial fractures. Of interest, however, is that this was not the 
case in orthopaedic implant surgery where no preoperative contamination was 
demonstrated (Harrison et al, 2002; Harrison et al, 2004). 
 
1.4.3 HIV and Wound Healing in the Absence of Infection 
 
HIV is a multisystem disease that causes chronic illness and this is not only through 
its association with infection. Immunological disease such as HIV-associated 
nephropathy, cardiomyopathy, encephalopathy, peripheral neuropathy, malignancy 
and pancytopaenia are a few examples of non-infective HIV pathologies causing 
chronic illness. The question then arises as to whether HIV-positivity per se will 
impair wound healing. Hewitt et al (1996) showed no significant difference in time 
taken to full wound healing between HIV-positive and -negative patients undergoing 
elective haemorrhoidectomy. In addition, they did not demonstrate a difference in 
healing between HIV-positive patients and those patients with a clinical diagnosis of 
Acquired Immunodeficiency Syndrome (AIDS), as defined by the 1993 Centers for 
Disease control (CDC) criteria. These finding are however, not confirmed by other 
studies. 
 
In a retrospective review of anorectal surgical procedures by Safavi et al (1991), 
wound healing was significantly poorer in patients with clinical AIDS compared to 
the earlier stage HIV-positive patients.  Lord (1997) showed that only 40% of 
anorectal wounds in HIV-positive patients were healed by three months. 
Other studies looking at healing following anorectal surgical procedures have shown 
that HIV-negative patients heal quicker than those who are HIV-positive. Patients 
with AIDS appear to display the longest time to healing (Morandi et al, 1999; Nadal 















There are varying reports on the impact of CD4 count on anorectal wound healing, 
with some studies showing no association (Eriguchi et al, 1997; Hewitt et al, 1996; 
Safavi et al, 1991) and others demonstrating a significant link between lower counts 
and delayed wound healing (Morandi et al, 1999; Nadal et al, 1998). 
Literature investigating the relationship between HIV infection, CD4 counts, wound 
sepsis and healing outcomes in emergency and elective surgery is available, but there 




1.5 Functional outcomes after OASI 
 
1.5.1 Anal Incontinence 
 
Anal incontinence refers to one or more of faecal (solid or liquid stool), and/or flatal 
incontinence.  As discussed previously, rates of anal incontinence vary after OASI, 
with overall rates of between 20 and 61% (Pinta et al, 2004; Rieger et al, 2004; Sultan 
et al, 1994; Walsh et al, 1996). A number of studies have shown anal incontinence 
rates for solid stool ranging from 7-20%, liquid stool incontinence from 8-18%, flatal 
incontinence from 7-41% and faecal urgency from 6-26% (Fornell et al, 2005; 
Gjessing et al, 1998; Pinta et al, 2004; Poen et al, 1998; Rieger et al, 2004; Sultan et 
al, 1994; Walsh et al, 1996; Wood et al, 1998). 
 
Fornell et al (2005) studied women 10 years after OASI. In their cohort where they 
had an 80% follow-up rate, five of their original 51 women with OASI had undergone 
secondary repair. The remainder reported significant incontinence to flatus and liquid 
stool compared to controls.  
 
Anal continence can be assessed by history, examination and special investigations 
(Sultan & Thakar, 2002). Symptoms include incontinence to flatus, liquid stool, solid 
stool and faecal urgency. These are best assessed using continence and quality of life 
questionnaires. 
Clinical vaginal and rectal examination includes assessment of wound healing, 














Useful special investigations include endoanal ultrasonography to look for a defect in 
the IAS and/or EAS, and anal manometry.  Pudendal nerve terminal motor nerve 
latency testing has not been shown to be of benefit and is not standard practice (Poen 
et al, 1998; Sultan et al, 1994). 
Endoanal ultrasonography can demonstrate defects in the internal and/or external anal 
sphincter. Defects have been detected in 15-88% of women after OASI, and 20-33% 
of controls (Pinta et al, 2004; Poen et al, 1998; Rieger et al, 2004; Sultan et al, 1994; 
Sultan et al, 1999). Anal incontinence is associated with defects in the IAS, EAS or 
both (Poen et al, 1998; Sultan et al, 1994).  
Mackenzie et al (2003) showed no direct relationship between defects detected on 
ultrasound and symptoms of anal incontinence. Rieger et al (2004) also failed to show 
a statistically significant association between symptoms and an ultrasonographically 
detected sphincter defect. Women with sonographically demonstrated defects can also 
be completely asymptomatic, whereas 31-80% of symptomatic women have no 
demonstrable sphincter defect (Gjessing et al, 1998; Poen et al, 1998; Sultan et al, 
1994). Sultan et al (1994) looked specifically at endoanal ultrasonography in women 
who had sustained an OASI, and found that 85% had a demonstrable defect whilst 
only 47% had symptoms. 
 
Anal manometry measures the maximum resting pressure of the anal sphincter, and 
the maximum squeeze pressure. Maximum resting pressure has been shown to be 
significantly lower in women with faecal incontinence and OASI (Fornell et al, 2005; 
Gjessing et al, 1998; Sultan et al, 1994). Maximum squeeze pressure is lower in 
women with OASI, and this has been shown to deteriorate with time. Lower 
maximum squeeze pressures are however not always associated with incontinence 
symptoms (Fornell et al, 2005; Gjessing et al, 1998; Pinta et al, 2004; Poen et al, 
1998). 
 
1.5.2 Urinary Incontinence 
 
Urinary incontinence is associated with normal vaginal delivery both in the absence 
and presence of OASI. The rates of urinary incontinence following vaginal delivery 
with OASI range from 13-50%, compared to 9-40% in the absence of sphincter 














& Laurin, 2003).  In the retrospective case-control study of 654 women by Wagenius 
and Laurin (2003), there was no significant difference in the rate of urinary 
incontinence between women with OASI and controls. Borello-France et al (2006) 
also did not detect a difference in urinary incontinence between controls and subjects 




1.5.3 Sexual function 
 
Sexual function depends on a complex interplay of many variables. In addition to 
physical factors in the postpartum period, psychological, emotional and 
environmental factors also play an important role in sexual function. Deterioration in 
sexual function during pregnancy and the postpartum period have been linked to 
depression and fatigue. However, relationship satisfaction is a protective factor for 
sexual desire and satisfaction (DeJudicibus & McCabe, 2002). 
  
Rates of dyspareunia in the first 2-3 months postpartum in women delivering 
vaginally range from 41-45% (Goetsch, 2000; Signorello et al, 2001). Although 
dyspareunia is common in women with an intact perineum or first degree tear, 
Signorello et al (2001) report that women with a third or fourth degree tear have a two 
to three-fold increase in dyspareunia at three months. Other studies have confirmed 
the increased incidence of dyspareunia at three months in women with higher order 
perineal injuries (Andrews et al, 2007). The study of Norderval et al (2005) reported 
de novo dyspareunia in 15% of women at a mean of 27 months after OASI. 
 
Ability to achieve orgasm, sexual sensation and satisfaction were poorer at six months 
postpartum in the study by Signorello et al (2001), compared to these parameters 
antenatally. On the other hand, Fornell et al (2005) showed no difference in libido, 
ability to achieve orgasm or enjoyment of sexual intercourse between study and 
control groups either at six months or ten years after injury. Lubrication at arousal 
was the only parameter that was impaired in their study group at six months, but this 














associated with episiotomy, but no relationship has been demonstrated between 
episiotomy and arousal, orgasm or sexual satisfaction (Ejegård et al, 2008). 
One study has reported that 17% of women experienced anal incontinence during 
sexual intercourse after OASI (Gjessing et al, 1998). No other studies have 
documented anal incontinence during intercourse. 
 
1.5.4 Perineal pain 
 
Postpartum perineal pain can impair the activities of daily living such as walking, 
sitting and driving.  It is reported that on day one postpartum, 75% of women with an 
intact perineum, 95% of women with first- or second-degree tears, and 100% of those 
with an OASI, report significant perineal pain (Macarthur & Macarthur, 2004).  
Pain remains on day seven for women with OASI, with 91% still reporting pain 
compared to only 38% for an intact perineum and 60% for a first or second-degree 
tear. At six weeks postpartum, there was no significant difference between rates of 
pain in any of the above groups of women. 
 
There is a paucity of further data on perineal pain after anal sphincter injury with most 
of the literature reporting on pain after episiotomy or in relation to repair techniques 




























Chapter 2: Materials and Methods 
 
2.1  Study Aims  
 
The primary aim of this study was to determine whether HIV-positive patients have 
poorer functional anal continence outcomes after OASI, than an HIV-negative control 
group, at similar time points postpartum.  
 
Secondary aims of the study were to determine:  
 Whether HIV infection confers a longer time to healing, and more 
complications, after an OASI; 
 The incidence of all types of perineal complications in our study population 
after OASI irrespective of HIV status; 
and  




2.2  Study Objectives 
 
The objectives of the study were to determine: 
1. The differences in anal incontinence, urinary incontinence, sexual dysfunction 
and perineal pain after OASI in HIV-positive and HIV-negative patients 
compared to their pre-delivery status  
2. The relationship of surgical technique to functional outcomes in our patients 
where the surgeons are usually Obstetrics and Gynaecology registrars 
3. The incidence and effect of the use of prophylactic antibiotics after anal 
sphincter repair 
4. The relationship of CD4 count to rates of healing, complications and functional 
outcomes in the HIV-positive patient group 
5. The role of antiretroviral therapy, if any, on healing and outcomes after OASI in 















2.3  Study Setting 
 
The study was performed in the Cape Town metropolitan area, where there is a tiered 
obstetric healthcare system. This falls within the design of the Comprehensive Service 
Plan (CSP) for the Implementation of Healthcare 2010, as published by the Western 
Cape Department of Health in 2007. Levels of care include primary, secondary and 
tertiary.  A well designed referral system exists whereby patients are seen at, or 
referred to, different levels of care as appropriate. The metropole has two tertiary 
centres, including Groote Schuur and Tygerberg Hospitals. The University of Cape 
Town is associated with Groote Schuur Hospital, and it is within this hospital’s 
drainage area that the study was performed.  
 
Primary level care is offered by midwives at Midwife Obstetric Units (MOUs). 
Secondary level care is by referral to Mowbray Maternity and New Somerset 
Hospitals. These two hospitals refer to the tertiary Groote Schuur Hospital when 
necessary. Only the secondary and tertiary hospitals have full-time cover by doctors. 
Care is rendered by consultants, registrars, medical officers and interns. Any 
identified OASI occurring at primary care level is referred to one of the above three 
hospitals as per the referral drainage design. 
Perinatal Problem Identification Programme (PPIP) statistics for 2006 reported more 
than 34 000 deliveries of more than 1kg in the Cape Town metropole falling under the 
Groote Schuur Hospital drainage and referral system. Of these, approximately 16 000 
were at primary care level, 14 000 at secondary care level, and 5 000 at tertiary level. 
 
All patients are routinely offered HIV testing at booking. Dedicated HIV counsellors 
are responsible for this testing. The result is stamped onto the antenatal card after the 
patient has been informed of the result and counselled. If she is HIV-positive, a CD4 
count is performed. 
 
All antenatal HIV-positive patients with a CD4 count of less than 200 are referred to 
an HIV clinic in the area where they live, where they are offered Highly Active 
Antiretroviral Therapy (HAART). This medication is dispensed by doctors at the HIV 
clinics and not the obstetric doctors. Patients continue their care at these HIV clinics 














antiretrovirals antenatally according to the Provincial Health Department’s Prevention 
of Mother-to-Child Transmission (PMTCT) guidelines. At present this includes 
zidovudine (AZT) 300mg bd orally from 28 weeks gestation until delivery, and 
Nevirapine 200mg orally within the 12 hours prior to delivery.  
 
 
2.4  Study Design 
 
This study was a prospective cohort study. The first part of the study involved 
recruiting the patients sustaining an OASI from labour ward and/or theatre records, 
while they were still in hospital. At recruitment, demographic details, relevant details 
of the injury, the surgical repair and the patient’s immediate post-operative course 
were documented. Information regarding pre-pregnancy anal continence, urinary 
continence, sexual function and perineal pain was recorded, using questionnaires 
during an interview with the patients. Patients were then given a referral letter to the 
Groote Schuur Hospital Perineal Clinic for follow-up six weeks after sphincter repair. 
It was at this follow-up visit that the second part of the study took place. 
 
At the six week follow-up visit, patients were assessed for symptoms of anal 
incontinence, urinary incontinence, sexual dysfunction and perineal pain by interview, 
using the same questionnaires. Any history of interim complications or re-admission 
was noted. The patients were examined to clinically assess wound healing, anal tone 
and to assess them for any clinical evidence of a sphincter defect.   
Anorectal manometry and endoanal ultrasonography were not performed. The main 
outcome measures of the current study were clinical assessment of functional 
symptoms experienced by the patients, and physical signs on examination. 
 
Although enrolment was allowed by any suitably qualified participating medical 
practitioner, ultimately the patients were only enrolled by the principal investigators. 


















2.5  Patient Recruitment 
 
Since patients with OASI are treated at either Somerset, Mowbray or Groote Schuur 
Hospitals, they were enrolled from the wards of these hospitals while still in-patients, 
in the immediate post-partum period.  
 
Any woman between the ages of 18 and 70, of any parity and race, who had sustained 
a third or fourth degree perineal laceration was considered suitable for recruitment. 
Both HIV-positive and HIV-negative women were enrolled. There had to be 
documented evidence in the patient’s folder as to her HIV status, and word of mouth 
status was not accepted. A negative HIV test in pregnancy was accepted and not re-
tested. The HIV-positive women acted as cases, and the HIV-negative women as the 
controls. Patients had to be able to communicate English or Afrikaans for the purpose 
of accurate informed consent and data collection, and completion of questionnaires. 
Exclusion criteria were an unknown or unproven HIV status, or a previous obstetric 
anal sphincter injury. 
 
The study was publicised in the three hospitals, and data collected by the principal 
investigators.  The patients were given a study referral letter at enrolment, so that at 
the 6 week follow-up visit they could be clearly identified as study participants. 
 
During the second part of the study, follow-up questionnaires and the clinical 
examination were completed by the principal investigators at the Groote Schuur 
Hospital Perineal Clinic. 
 
The women were each advised that should she have complications between discharge 
from hospital and the six week follow-up visit, she should contact the Groote Schuur 
Perineal Clinic or her local Day Hospital for assessment.  
 
Enrolment began in September 2008 after approval for the study was obtained from 
the University of Cape Town’s Faculty of Health Sciences Ethics Committee (REC 
















2.6  Data Collection 
 
All data for the study was collected by the principal investigators, who alone had 
access to the completed data sheets, consent forms, and enrolment logs. After 
indentifying eligible study participants, the investigators explained the study to the 
patients and provided them with a patient information sheet designed for the study, 
and if the patient agreed to participate, an informed consent form was signed by the 
patient (See Appendices 1 and 2). 
 
Data collection sheets were designed by the principal investigators, and included use 
of recognised scoring and assessment systems, specifically the Wexner Score for anal 
incontinence (Vaizey et al, 1999), a 10 point Visual Analogue Scale (VAS) for 
perineal pain, and the Abbreviated Sexual Function Questionnaire (ASFQ) for sexual 
function (Guay A et al, 2004). The same data questionnaires were used for both parts 
of the study. The only differences in the data collection sheets for the two parts of the 
study were the inclusion of a demographics proforma for the first part of the study, 
and a clinical examination proforma for the second part (follow-up visit). (See 
Appendix 3). 
 
The data was immediately entered onto an Excel Spreadsheet on a password 
controlled computer, accessed only by the principal investigators. Original paper data 
was kept in a secure locked location accessed only by principal investigators.  
 
An Enrolment Log kept a record all eligible participants, and whether or not they 




2.7  Sample Size and Statistical Analysis 
 
The sample size calculations for this study were based on a significance level of 0.05 
and an intention for the study to have at least 80% power. 
We estimated an event rate of 20% for symptoms of anal incontinence amongst HIV-














The literature suggests that 50% of HIV-positive women will not heal completely 
(Lord, 1997; Morandi et al, 1999; Safavi et al, 1991). It was thus deemed likely that 
these women would have symptoms of anal incontinence. We therefore estimated an 
event rate of 50% amongst the HIV-positive women.  
 
Using the lowest incidence quoted of 0.6% of deliveries being complicated by OASI, 
we anticipated at least 200 OASIs in our service annually. Using the Stata Statisitics 
programme, a sample size of 100 HIV-negative and 50 HIV-positive patients was 
determined to give the study a power of 94%. This confirmed that the study would 
have adequate statistical power to detect a clinically meaningful difference in the 
occurrence of incontinence following OASI between HIV-positive and HIV-negative 
women. 
 
Data entered into the Excel Spreadsheet was transferred to the SPSS 17.0 Statistical 
Analysis Program. Frequencies and descriptive figures were determined for the data, 
and tests for significance were calculated using the Mann-Whitney Test, after 
application of the Shapiro-Wilk test indicated that the data was not normally 
distributed. 
In addition, online interactive statistical programs were used to determine Fisher’s 




2.8  Ethical Considerations 
 
Ethical approval for the study was granted by the University of Cape Town Faculty of 
Health Science’s Ethics Committee (REC REF 276/2008; see Appendix 4). 
 
The patient information sheet, as well an explanation by the recruiting doctor, served 
to enable the patients to make an informed decision on whether or not to consent to 
being enrolled in the study. An informed consent form was signed by participants, a 
principal investigator and one witness. Enrolment was on a purely voluntary basis, 
and it was made clear to patients that their HIV status would be documented, as well 














would involve a clinical examination at the six week follow-up visit. Patients unable 
to legally give their own consent would be invited to join in the study if they and that 
person with their power-of-attorney consented to their participation. However, all 
patients enrolled were able to consent for themselves. Of note, the Ethics Committee 
Approval designated that only women older than 18 year of age be enrolled. 
 
Due to the extreme sensitivity of studying outcomes of HIV status, priority was 
placed on ensuring complete confidentiality once a patient was enrolled. Only the 
patient’s folder number and study number was recorded on the data collection sheets, 
with no names documented. However, a separate patient tracking sheet was used to 
keep a record of the patient’s name, folder number, study number and her contact 
details. This was used to contact the patient only if she did not attend her follow-up 
appointment, in order to give her the opportunity of rescheduling if she so chose. The 
patient tracking sheet was kept securely by the principal investigators, in a file 
separate to the data collection sheets.  
Folder numbers and names were not entered into the password-controlled computer 
database. A separate and confidential master participation sheet kept a record of 
patient folder numbers linked to study numbers. Only the principal investigators had 
access to the original data collection sheets, patient tracking sheets, consent forms, 
master participation sheet and the enrollment log. Patients were recruited in private. 
 
Any patient choosing not to be enrolled in the study still had access to follow-up at 
the Groote Schuur Perineal Clinic, through routine inter-hospital referral by their 
discharging doctor. Thus there was no discrimination of care to those choosing not to 
be enrolled in the study.  Patients were advised of this. 
 
Patients enrolling in the study were reimbursed for the transport costs to their follow-
up appointments. This was to try and ensure that the cost of transport did not keep 
asymptomatic patients away from their follow-up appointment, and to ensure no 
financial burden was placed on the patient by being enrolled in the study. 
Reimbursement took place at the Perineal Clinic and not in advance. Reimbursement 















There was no new procedure, drug or technique being studied on the patients 
enrolling in this study. There was no extra care being provided to the patients in this 
study, and there were no health risks to being enrolled in the study. The only 
potentially negative effects of this study on the participants were if they felt 
embarrassed about the nature of the information obtained, questions asked or 
examination performed, and the possible inconvenience of attending the follow-up 
visit.  
It was anticipated that this study would actually be of benefit to all patients invited to 
participate, even if they declined enrolment. The main advantages included that the 
study highlighted to the patients exactly what type of injury they sustained, how and 
why it was repaired and the potential adverse consequences. They were also made 
aware that help was available should she experience any complications, and exactly 
how and where to access this specialised help and follow-up. There were no direct 
health benefits resulting from enrolment that would not be otherwise available. 
 
The fact that only patients who could communicate in English or Afrikaans were 
enrolled in the study was in order to protect the patients. The study focussed on two 
very sensitive issues, namely HIV status and anal continence, and we did not wish to 
enrol patients who may be at a disadvantage if they did not fully understand the nature 
of the study. We did not want language difficulties to compromise the patient’s right 
to autonomy and privacy, nor to result in inaccurate data collection. 
 
The Declaration of Helsinki (2000) and the Guidelines for Good Practice in the 
Conduct of Clinical Trials in Human Participants in South Africa [2008], were both 





The costs of the study were carried by the principal investigators. There was no 




















From 1 September 2008 to 31 July 2009, 90 patients with OASI were identified. 
Sixty-eight of these women were enrolled in the study (Figure 1). Fifteen patients 
were not enrolled due to discharge prior to enrolment and these women were also not 
referred to the Groote Schuur Hospital Perineal Clinic, nor were they contactable 
from details in hospital records. Four patients were too young for enrolment (<18 
years); two women were recorded as having OASI but on examination of patient and 
theatre notes this could not be confirmed; and one patient was excluded due to having 
had a previous OASI.  Only 36 patients attended the Perineal Clinic for follow-up at 
the time of analysis, resulting in a loss to follow up of 47.1%. Of the 32 patients lost 
to follow up, the majority were untraceable using the contact details given at 
enrolment, whilst a minority were no longer in the area, and others did not give a 
reason for not following up. 
 




90 Women  
Identified 
22 Women  
Not enrolled 
68 Women  
Enrolled 
15 Women  
Eligible but not enrolled 
4 Women 
Not eligible due to age 
2 Women  
















At baseline, three demographic parameters were assessed (Table 1). 
The age and parity of the women were not normally distributed. The median age of all the 
women was 24 and the median parity was 1. Forty-seven women were Black (69.1%), twenty 
(29.4%) were Coloured, and one (1.5%) was White. Of the 68 women, 14 (20.6%) were HIV-
positive and 54 (79.4%) were HIV-negative. 
 
There was a statistically significant difference in age and ethnic group between the HIV-
positive and HIV-negative women with an OASI (Table 1), with HIV-positive women being 
older and of the Black ethnic group. 
 
 
Table 1 Demographic characteristics of women enrolled in study 
 Total Sample 
(n=68) 
 
HIV pos  
(n=14) 
HIV neg  
(n=54) 
p-value 
Median Age 24 (21-26)* 27 (23-32)* 24 (20-26)* 0.03# 
Median Parity 1 (1-2)* 1 (1-1)* 1 (1-2)* 0.24# 
Ethnic Group     
   Black 47 (69.1%) 14 (100%) 33 (61.1%)  0.0001† 
   Coloured 20 (29.4%) 0 20 (37.0%)  1.00† 
   White 1 (1.5%) 0 1 (1.9%)      1.00† 
*Inter-quartile range 
#Mann-Whitney Test 




3.2  CD4 counts and Treatment of HIV-positive patients 
 
Of the 14 HIV-positive women, the mean CD4 count was 351 (SD +/- 152.9), with a range of 
105 to 560.  Three women had a CD4 count less than 200,  seven women had a CD4 count 














All of the women were on anti-retroviral therapy (ART). Five women were on the Perinatal 
Mother-to-Child Transmission (PMTCT) prevention program, all of whom had CD4 counts 
between 200 and 500; and nine women were on Highly Active Anti-retroviral Therapy 














  28.6% 
  n=4 
 
  50% 
  n=7 
 
 
  21.4% 





    
    22.2% 












CD4<200 CD4 200-500 CD4>500 
CD4 Count 
















3.3 Distribution of OASI 
 
Of the 68 women, 16 (23.5%) sustained a 3a tear, 13 (19.1%) a 3b tear, 10 (14.7%) a 3c tear, 
and 20 (29.4%) sustained a fourth degree tear.  Nine (13.2%) tears were not classified in the 
patient’s delivery or operation notes (Figure 3). There was no statistically significant difference 
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3a 3b 3c 4 Not specified 


















3.4 Management of OASI 
 
Twenty-six (38.2%) tears were repaired by the end-to-end method, 27 (39.7%) by the overlap 
technique, and in 15 (22.1%) patients the technique used was not described in the patient’s 
notes (Figure 4). There was no significant difference between the technique of repair employed 
if the patient was HIV-positive or –negative. 
Antibiotics were prescribed for 66 (97.1%) of the women enrolled. The two women not 
receiving antibiotics were both were HIV-negative. 
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Total Sample (n=68) 
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3.5 Pre-pregnancy Functional Assessment 
 
3.5.1 Anal Continence 
 
Table 2 depicts the Wexner scoring system. Each category is assigned a score of 0-4 and the 
overall Wexner score for the five categories gives a score out of 20. The mean Wexner Score 
prior to the index pregnancy in our study was 0.4 (Table 3). Mean scores for solid stool 
incontinence, liquid stool incontinence, flatal incontinence, pad usage and lifestyle impact were 
low throughout the sample, with no significant differences between the HIV-positive and HIV-






















 Table 2 The Wexner Score 
 
 












Solid Stool Incontinence 
 
0 1 2 3 4 
Liquid Stool Incontinence 
 
0 1 2 3 4 
Flatal Incontinence 
 
0 1 2 3 4 
Pad Usage for Faecal 
Incontinence 
 
0 1 2 3 4 
Lifestyle Impact 
 
0 1 2 3 4 
0   = perfect continence   




Table 3 Pre-pregnancy Wexner Scores for anal continence 
Mean Wexner Score§  Total 
Sample 
(n=68) 
HIV Pos   
 
(n=14) 




Overall Wexner Score (0-20) 0.4 0.6 0.4 0.70 
Solid Stool Incontinence (0-4) 0.0 0.0 0.0 - 
Liquid Stool Incontinence (0-4) 0.1 0.1 0.1 0.94 
Flatal Incontinence (0-4) 0.1 0.3 0.1 0.62 
Pad usage for Faecal Incontinence 
(0-4) 
 
0.1 0.1 0.1 0.95 
Lifestyle Impact (0-4) 0.1 0.1 0.1 0.93 
*Mann-Whitney  

















3.5.2 Perineal Pain 
 
Using a visual analogue pain scale, graded 0-10 (with 0 being no pain at all), all 68 women 
reported almost no pain of the perineum on walking, sitting and resting (Table 4).  All mean 
scores were less than 1, with no differences between the two groups (Table 4). 
 
Table 4 Mean pre-pregnancy pain score by visual analogue scale 







Walking 0.2 0.1 0.2 0.79 
Sitting 0.3 0.1 0.4 0.97 
Resting 0.1 0.0 0.1 0.92 
*Mann-Whitney 
 
3.5.3 Urinary Function and Symptoms 
 
A statistically significant difference was found between the HIV-positive and -negative women 
in the experience of urgency prior to the index pregnancy (p=0.01; Table 5). A total of 15 
(22.1%) women experienced urgency in the entire cohort, with only eight out of 54 HIV-
negative women (14.8%) experiencing urgency, while seven of the 14 HIV-positive women 
(50%) reported experiencing urgency (p=0.01; Table 5).  Eight (14.8%) of the HIV-negative 
women also experienced urge incontinence, and three (21.4%) of the HIV-positive women 
suffered from urge incontinence (p=0.68; Table 5).  
 
There was no difference in urge or stress incontinence between the two groups (Table 5). The 
incidence of both stress and urge incontinence was 16.2% across the entire cohort (Table 5). 
The most prominent urinary symptoms for the entire sample were double-voiding (13.2%) and 
post-micturition dribbling (11.8%). Less commonly, straining (5.9%), hesitancy (7.4%), poor 
stream (5.9%) and incomplete emptying (5.9%) were reported by the cohort. There was 
















Table 5 Pre-pregnancy urinary function and symptoms 











3.9 3.9 3.9 0.45* 
Mean Nocturia 
(#) 
1.1 1.4 1.0 0.16* 
Urgency 15 (22.1%) 7 (50.0%) 8 (14.8%) 0.01† 
Urge 
Incontinence 
11 (16.2%) 3 (21.4%) 8 (14.8%) 0.68† 
Stress 
Incontinence 
11 (16.2%) 2 (14.3%) 9 (16.7%) 1.00† 
Straining 4 (5.9%) 1 (7.1%) 3 (5.6%) 1.00† 
Hesitancy 5 (7.4%) 0 5 (9.3%) 0.58† 
Poor Stream 4 (5.9%) 1 (7.1%) 3 (5.6%) 1.00† 
Double 
Voiding  
9 (13.2%) 2 (14.3%) 7 (13.0%) 1.00† 
Incomplete 
Emptying 




8 (11.8%) 3 (21.4%) 5 (9.3%) 0.35† 
*Mann-Whitney Test 
†Fisher’s Exact Test 
 
The mean number of voids per day was 3.9, which was comparable between the two groups 
(p=0.45; Table 5). The mean number of voids during the night was 1.1, again comparable 
between the HIV-positive and HIV-negative groups (p=0.16; Table 5).  
 
 
3.5.4 Sexual Function 
 
The mean scores on the Abbreviated Sexual Function Questionnaire (ASFQ) were higher in the 
HIV-negative group for 13 out of the 15 domains (Table 6). However, only two of these 
domains reached statistical significance: those for the frequency of experiencing vaginal 














the vaginal/genital area during intercourse (Domain 10; p=0.04) (see Table 6). The frequency 
of vaginal/genital “pulsating/tingling” was higher in the HIV-negative group, but did not reach 
statistical significance (Domain 9; p=0.06). 
 
Table 6 Abbreviated Sexual Function Questionnaire Mean Scores 








1. Frequency of pleasurable thoughts 
about sexual activity (1-5) 
3.0 3.0 3.1 0.82 
2. Desire to be sensually touched or 
caressed (1-5) 
3.2 3.1 3.3 0.48 
3. Desire to participate in sexual 
activity (1-5) 
3.1 3.1 3.0 0.90 
4. Frequency of initiation of sexual 
activity (1-5) 
2.4 1.9 2.6 0.09 
5. Frequency of intercourse with 
vaginal penetration (0-6) 
1.9 2.0 1.9 0.72 
6. Glad anticipation of sexual activity 
(1-5) 
3.2 2.7 3.3 0.07 
7. Frequency of vaginal warmth 
during sexual activity (0-5) 
3.0 2.4 3.1 0.09 
8. Quantity of vaginal warmth during 
sexual activity (0-5) 
2.5 2.4 2.5 0.68 
9. Frequency of vaginal/perineal 
“pulsating/tingling” sensation during 
sexual activity (0-5) 
2.0 1.5 2.2 0.06 
10. Quantity of vaginal/perineal 
“pulsating/tingling” sensation during 
sexual activity (0-5) 
2.0 1.5 2.2 0.04 
11. Frequency of vaginal 
wetness/lubrication during sexual 
activity (0-5) 
3.4 2.8 3.6 0.02 
12. Quantity of vaginal 
wetness/lubrication during sexual 
activity (0-5) 
2.8 2.5 2.9 0.14 
13. Frequency of experiencing 
orgasm (0-5) 
2.8 2.3 3.0 0.09 
14. Quality of orgasms experienced 
(0-5) 
3.3 2.8 3.4 0.44 
15. Ease of reaching orgasm (0-5) 2.7 2.1 2.8 0.14 
*Mann-Whitney 














The only two domains in which the HIV-positive women scored higher AFSQ mean scores, 
were in the desire to have intercourse (Domain 3), and the frequency of intercourse (Domain 5) 
(Table 6). These higher scores also did not reach statistical significance. 
 
 
3.6 Postpartum Healing and Functional Assessment 
 
3.6.1 Postpartum Clinical Examination 
 
Of the 38 women who were followed up at an average of six weeks postpartum, 28 (77.8%) 
were completely healed clinically (Table 7). Only two (5.6%) women had evidence of 
infection, and both of these women were HIV-negative. These were not the two women who 
were not prescribed antibiotics.  Three (8.3%) women had a partial dehiscence of the anal 
sphincter, and seven (19.4%) had a granuloma (Table 7).  Twenty-five of the 36 (69.4%) 
women followed up had normal sphincter tone, the remaining 11 (30.6%) had decreased 
sphincter tone (Table 7).  Clinically, 27 (75%) women had sphincters that were completely 
intact, and nine (25%) had a partial defect palpable (Table 7). None of the women had a 
complete sphincter defect clinically. 
 
At follow-up, 16 (44.4%) women experienced perineal pain to touch (Table 7). The most 
common area for pain to be felt was at the 10 o’clock through 2 o’clock positions (See 
Appendix 3). The mean Oxford score for the cohort of women at follow-up was 2.3 (Table 7), 
with a score range of 0 to 5. 
 
The HIV-positive women had a higher percentage of poorer wound healing than the HIV-
negative women (87.5% vs 75.0%; p=0.65) and less evidence of current infection (0% vs 
7.1%; p=1.00) (Table 7). They were also more likely to have a partial wound dehiscence 
(12.5% vs 7.1%; p=0.54), decreased sphincter tone (50% vs 25%; p=0.21), a partial sphincter 
defect (37,5% vs 21.4%; p=0.38) and more perineal pain (62,5% vs 39,3%; p=0.42) than their 

















Table 7 Clinical examination findings at 6 weeks postpartum 








Complete healing 28 (77.8%) 7 (87.5%) 21 (75.0%) 0.65† 




 3  (8.3%) 1 (12.5%) 2  (7.1%) 0.54† 
Granuloma  7  (19.4%) 1 (12.5%) 6  (21.4%) 1.00† 
Normal tone 25 (69.4%) 4 (50.0%) 21 (75.0%) 0.21† 












0 0 0 - 
Oxford Score 2.3 2.3 2.4 0.72* 
Perineal Pain present 16 (44.4%) 5 (62.5%) 11 (39.3%) 0.42† 
*Mann-Whitney 
† Fisher’s exact test 
 
3.6.2 Postpartum Anal Continence Assessment 
 
The mean overall Wexner Score (out of 20) at six weeks postpartum was 1.3 (Table 8). The 
HIV-positive women had a higher overall Wexner Score at this time, but the difference was not 
statistically significant (p=0.21) (Table 8).  
The mean Wexner Score for solid stool incontinence was 0.3, and this score was higher 
amongst the HIV-positive women, but not statistically significant (p=0.36) (Table 8). The HIV-
positive women also had a higher mean Wexner Score for liquid stool incontinence (0.3 vs 
0.2), flatal incontinence (0.4 vs 0.1) and pad usage for purpose of faecal incontinence (0.9 vs 














for lifestyle impact was 0.3, again higher in the HIV-positive women but not statistically 
significant (p=0.18) (Table 8). Only two women had a Wexner score greater than 10, and both 
of these patients had sustained a 3b tear. 
 
Table 8 Wexner Scores of anal continence at 6 weeks postpartum 
Mean Wexner Score§  Total 
Sample 
(n=36) 
HIV Pos  
 
(n=8) 




Overall Wexner Score (0-20) 1.3 3.3 0.8 0.21 
Solid Stool Incontinence (0-4) 0.3 0.9 0.1 0.36 
Liquid Stool Incontinence (0-4) 0.2 0.3 0.2 0.51 
Flatal Incontinence (0-4) 0.2 0.4 0.1 0.72 
Pad usage for purpose of Faecal 
Incontinence (0-4) 
 
0.4 0.9 0.3 0.24 
Lifestyle Impact (0-4) 0.3 0.9 0.1 0.18 
*Mann-Whitney 
§Score range given in brackets 
 
Table 9 Relative Risk of Anal Continence Events  
Women with events (#) HIV Pos  
(n=8) 
 
HIV Neg  
(n=28) 
Relative Risk  
(95% Confidence Interval) 
Solid Stool Incontinence 2 1 7.0   (0.98-48.86) 
Liquid Stool Incontinence 2 2 3.5   (0.66-17.14) 
Flatal Incontinence 1 1 3.5   (0.38-30.63) 
Pad Usage for Anal Incontinence 3 2 5.3   (1.16-22.72) 
Lifestyle Impact 3 2 5.3   (1.16-22.72) 
Wexner Score >10 at 
6weeks post-partum 
 















The Relative Risk for solid stool incontinence in HIV-positive compared to HIV-
negative women was 7.0, approaching but not reaching statistical significance. The 
Relative Risk of Lifestyle Impact was significant at 5.3 (95% CI 1.16-22.72), as was 
the Relative Risk of requiring pad usage for anal incontinence, also being 5.3 (95% CI 
1.16-22.72) (Table 9). 
 
3.6.3  Postpartum Pain Assessment 
 
The mean visual analogue pain score on walking was 0.4, on sitting 0.5 and at rest 0.1 (Table 
10). The pain scores were lower in the HIV-positive group for sitting (0.3 vs 0.6) and resting 
(0.0 vs 0.1), but higher for pain on walking (0.5 vs 0.4). These differences did not reach 
statistical significance (Table 10). 
 
Table 10  Pain scores 6 weeks postpartum by visual analogue scale 
 Total Sample 
(n=36) 
 





Walking 0.4 0.5 0.4 0.96 
Sitting 0.5 0.3 0.6 0.72 
Resting 0.1 0.0 0.1 0.90 
*Mann-Whitney 
 
3.6.4 Postpartum Urinary Symptoms and Function 
 
The mean number of daily voids at six weeks postpartum was 3.6 for the 36 women who 
attended follow-up. The mean number of night-time voids was 1.3 (Table 11). 
Ten (27.8%) women said they experienced urgency, but the difference in urgency between the 
HIV-positive and -negative women was not statistically significant (p=0.11) (Table 11). Six 
(16.7%) of all the women followed up reported urge incontinence (Table 11). 
Three (8.3%) of the women reported stress incontinence, all of whom were HIV-positive, and 














The mean frequency of stress incontinence in these women was 4.7, correlating to 
approximately 2 to 3 episodes of stress incontinence weekly.  
Only one (3.6%) woman reported straining, one (3.6%) reported hesitancy, one (3.6%) 
experienced poor stream and two (7.1%) reported double voiding (Table 11). All these women 
were HIV-negative, with no significant difference between the groups (Table 11). None of 
these women reported incomplete emptying or post-micturition dribbling (Table 11). 









daily (#)  
3.6 3.0 3.8 0.12* 
Mean Nocturia (#) 1.3 1.8 1.1 0.21* 
Urgency 10    (27.8%) 3     (37.5%) 7       (25.0%) 0.11† 
Urge Incontinence 6      (16.7%) 3     (37.5%) 3       (10.7%) 0.11† 
Stress Incontinence 3      (8.3%) 3     (37.5%) 0 0.01† 
Mean Frequency of 
Stress Incontinence 
(#) 
4.0 4.7 0 - 
Straining 1      (2.8%) 0 1       (3.6%) 1.00† 
Hesitancy 1      (2.8%) 0 1       (3.6%) 1.00† 
Poor Stream 1      (2.8%) 0 1       (3.6%) 1.00† 
Double Voiding 2      (5.6%) 0 2       (7.1%) 1.00† 
Incomplete 
Emptying 
0 0 0 1.00† 
Post-micturition 
Dribbling 
















3.6.5 Sexual Function postpartum 
 
Only five women had resumed sexual activity at the follow-up visit, three of whom were HIV- 
positive and two who were HIV-negative (Table 12). The mean ASFQ Scores were higher 
(indicating better function) in the HIV-negative women than in the HIV-positive women for all 
 
Table 12 Sexual Function 6-week post-partum 
Mean Score over a 4 week period§ Total 
Sample 
(n=5) 
HIV Pos  
 
(n=3) 




1. Frequncy of pleasurable thoughts   about 
sexual activity (1-5) 
1.4 1.3 1.5 0.80 
2. Desire to be sensually touched or 
caressed (1-5) 
2.0 1.3 3.0 0.20 
3. Desire to participate in sexual activity 
(1-5) 
1.2 1.0 1.5 0.40 
4. Frequency of initiation of sexual activity 
(1-5) 
1.2 1.0 1.5 0.40 
5. Frequency of intercourse with vaginal 
penetration (0-6) 
1.0 1.0 1.0 1.00 
6. Glad anticipationn of sexual activity  
(1-5) 
1.6 1.0 2.5 0.20 
7. Frequency of vaginal warmth during 
sexual activity (0-5) 
1.6 1.7 1.5 0.80 
8. Quantity of vaginal warmth during 
sexual activity (0-5) 
1.4 1.3 1.5 1.00 
9. Frequency of vaginal/perineal 
“pulsating/tingling” sensation during 
sexual activity (0-5) 
1.4 1.3 1.5 1.00 
10. Quantity of vaginal/perineal 
“pulsating/tingling” sensation during 
sexual activity (0-5) 
1.4 1.3 1.5 1.00 
11. Frequency of vaginal 
wetness/lubrication during sexual activity 
(0-5) 
2.8 3.0 2.5 0.80 
12.Quantity of vaginal wetness/lubrication 
during sexual activity (0-5) 
2.2 1.7 3.0 0.40 
13. Frequency of experiencing orgasm  
(0-5) 
1.6 1.0 2.5 0.20 
14. Quality of orgasms experienced (0-5) 
 
1.8 1.0 3.0 0.40 
15. Ease of reaching orgasm (0-5) 
 
2.0 1.0 3.5 0.20 


















domains except Domain 7 of vaginal warmth and Domain 11 of vaginal lubrication (Table 12), 
where the HIV-positive women scored higher. The highest mean AFSQ scores were 2.8 for the 
frequency of vaginal lubrication (Domain 11) and 2.2 for the quantity of vaginal lubrication 
(Domain 11). The lowest overall scores were for the frequency of intercourse (Domain 5; score 
= 1.0), desire to participate in sexual activity (Domain 3; score = 1.2) and initiation of sexual 
activity (Domain 4; score = 1.2) (Table 12).  
 
 
3.7 Relationship of Antibiotic Usage to Clinical Examination Findings 
 
Both of the women who were not prescribed antibiotics attended follow-up. Neither of these 
women had evidence of infection, wound dehiscence, granuloma, partial sphincter defect or 
decreased sphincter tone, but one of them experienced pain to touch (Table 13). 
 











2 (5.6%) 2 (5.9%) 0 1.00† 
Partial Dehiscence 
 
3 (8.3%) 3 (8.8%) 0 1.00† 
Granuloma 
 








11 (30.6%) 11 (32.4%) 0 1.00† 
Pain 
 
16 (44.4%) 15 (44.1%) 1 (50.0%) 1.00† 
 

















3.8 Relationship of Overall Wexner Score to Technique of Repair 
 
Seventeen (47.2%) of the women attending follow-up had an end-to-end repair, 11 
(30.6%) had an overlap repair and for eight (22.2%) the repair technique was 
unknown (Table 14). Only two women had an overall Wexner Score >10, one of 
which was associated with an end-to-end repair, and the other with an unknown repair 
technique. There was no association between an overall Wexner Score greater than or 
less than 10, and technique of repair (Table 14).  
 
Table 14  Relationship of Wexner Score to Technique of Repair 





End-to-end 17 (47.2%) 1 (50.0%) 16 (47.1%) 1.00  
Overlap 11 (30.6%) 0 11 (32.4%) 1.00 
Other 8 (22.2%) 1 (50.0%) 7 (20.6%) 0.40 





3.9 Relationship of CD4 count to clinical healing 
 
 
Table 15  Relationship of CD4 count to clinical healing findings 
 CD4<200 (n=3) CD4 200-500 (n=7) CD4 >500 (n=4) 
Wound not healed 1 0 0 
Infection 0 0 0 
Dehiscence 1 0 0 
Granuloma 1 0 0 
Wexner >=10 0 0 1 
Urgency pre-pregnancy 0 6 1 
 
One HIV-positive woman was not completely healed, and this patient had a CD4 count less 














granuloma and she also had a CD4 count less than 200 (Table 15). One patient with a CD4 
count greater than 500 was the only HIV-positive patient with an overall Wexner Score more 
than 10 out of 20 (Table 15). Six HIV-positive women experiencing urgency prior to 
pregnancy had a CD4 count of 200-500, and one had a CD4 count greater than 500. 
 
 
3.10 Relationship of Anti-retrovirals to clinical healing 
 
The one HIV-positive woman with a wound not completely healed was on the PMTCT 
program, and the one patient with wound dehiscence was on HAART. The woman with a 
Wexner Score >10 and a CD4 count >500 (Table 15), was on the PMTCT program (Table 16).  
 
Table 16 Relationship of Anti-retrovirals to Clinical Healing Findings 
 PMTCT (n=5) HAART (n=3) Nil (n=0) 
Wound not healed 1 0 0 
Dehiscence 0 1 0 
Granuloma 0 1 0 
Wexner >=10 1 0 0 
























Chapter 4:  Discussion 
 
The incidence of OASI in the literature is reported as 0.6-2.4%  (Fornell et al 1996; 
Sultan et al, 1994; Walsh et al, 1996). This approximates to a minimum of 187 OASIs 
that can be expected in our service annually. Our study indentified 90 women, giving 
an incidence of 0.26% annually and 0.24% in the 11 month enrolment period. This 
incidence is lower than rates reported in the literature, and it is suspected that OASIs 
are being underreported. A large proportion of our patients delivered with only a 
midwife in attendance. It is well established in the literature that detection of OASI is 
higher if doctors are in attendance at delivery (Andrews et al, 2006). We suspect that 
patients with OASI are being missed in our service. 
 
The incidence of HIV-positive women in our service was 20.6%, compared to the 
2006 estimate of 29.1% nationally and 15.2% in the Western Cape (South African 
Department of Health Study 2006). It is anticipated that the incidence of HIV-
positivity is increasing at a rate of 500 000 cases annually (ASSA 2003). This 
increase in prevalence in the Western Cape is in keeping with the anticipated rate of 
increasing HIV infection, and the national prevalence.  
 
This study showed that HIV-positive women with an OASI were significantly older in 
comparison to the HIV-negative women with an OASI (median age 27 years vs 24 
years). HIV-positive women with an OASI were also more likely to be of Black 
ethnicity. This is hard to account for, but the age difference is possibly due to the fact 
that older women are likely to have been sexually active for longer, and hence have 
more years of exposure to HIV infection. 
 
The mean CD4 count of the HIV-positive women in this study was 351. By current 
Western Cape protocols, only women with CD4 counts less than 200, (and most 
recently 250), qualify for Highly Active Antiretroviral Therapy (HAART). All 
women in this study were receiving some sort of Antiretroviral Therapy (ART), and 
the majority were receiving HAART (Figure 2).  It is reassuring that HIV-positive 
pregnant women are having their disease identified and managed, and that HAART is 















It is of interest that 29.4% of OASIs in this study were 4th degree tears, followed by 3a 
(23.5%), 3b (19.1%) and 3c tears (14.7%). Scheer at al (2008) report rates of 48%, 
42%, 5% and 5% for 4th, 3a, 3b, and 3c tears respectively. It is also unsurprising that 
the nature of injury was independent of HIV status. 
 
Only 36 of the 68 women enrolled in our study attended follow-up at six weeks. This 
is a loss to follow-up of 47.0%. The problem of loss to follow up after perineal injury 
is also reported by other authors (Garcia et al, 2005; Williams et al, 2005). The stress 
and time constraints of caring for a new baby, a possible reluctance to attend follow-
up in the absence of subjective problems, geographic migration and the cost 
limitations of attending hospital, may be the reasons for this high loss-to-follow-up 
rate. Unfortunately this large loss to follow-up severely compromises the power of the 
study and the consequent conclusions we are able to draw from the data. 
 
Pre-pregnancy anal continence assessment using the Wexner score showed no significant anal 
incontinence, as may be expected in a young, predominantly nulliparous population. Likewise, 
baseline pain scores were almost negligible. 
The postpartum anal incontinence experienced by our cohort as determined by Wexner scores 
was low in our cohort. The mean overall Wexner score was 1.3.  All scores for solid stool, 
liquid stool and flatal incontinence, as well as pad usage and lifestyle impact were higher in the 
HIV-positive women. None of these differences were significant however. This is likely 
related to small numbers of women who attended follow-up.  Of note, all mean scores on the 
Wexner analysis were 0.9 or less, which equates to rare episodes of incontinence, pad use or 
lifestyle impact ie less than once per month. 
 
We determined the relative risk of HIV-positive women developing solid stool 
incontinence to be 7.0 (95% CI 0.98-48.86), approaching but not reaching statistical 
significance. The HIV-positive women did however have a significantly higher 
relative risk of requiring the use of a pad for anal incontinence events post-injury (RR 
5.3; 95% CI 1.16-22.72) and for negative lifestyle impact (RR 5.3; 95% CI 1.16-
22.72). Of note is that these calculations of relative risk show slightly different 
statistical significance levels compared to the p-values reported previously. The 














occasions p-values do not correlate with 95% confidence intervals. The p-value is 
taken to be more accurate than a confidence interval in this circumstance. Thus we 
would have to conclude that the differences elicited may in fact not be significant, 
based on the p-values on Wexner score assessments. 
 
The one HIV-positive woman with a Wexner score greater than 10 had a CD4 count 
greater than 500, and had received ART as part of PMTCT program only. Again, it is 
not possible to draw conclusions about the impact of CD4 count and ART on OASI 
due to the small numbers followed up in this study.  
 
The technique of repair of OASI has been the subject of extensive investigation in the 
literature. Sultan et al (1999) first proposed the overlap technique as a viable repair 
option for OASI, and suggested it to be superior to the approximation technique. 
Subsequently there have been four RCTs investigate this issue, one which also 
compares different suture materials (Williams et al, 2005). Three of these trials 
showed no difference between the two techniques at three months follow-up 
(Fitzpatrick et al, 2000; Garcia et al, 2005; Williams et al, 2005), but the fourth trial 
showed better outcomes in the overlap group at 12 months post-repair, but not at three 
months postpartum (Fernando et al, 2006).  
Of note, the trial by Fitzpatrick et al (2000) did not repair the IAS separately to the 
EAS, nor were tears classified into 3a, 3b, 3c or 4th degree tears. Norderval et al 
(2005) specifically designed their trial to repair the IAS separately to the EAS. They 
showed better continence outcomes than previously documented figures, with a mean 
Wexner score of 1.13 in 62 patients followed up at an average of 27 months post 
repair. 
 
In the Cochrane review, Fernando et al (2006) suggested that the overlap repair may 
have better functional outcomes, but they did not go as far as recommending it 
beyond reasonable doubt. Lepistö et al (2008), however, recommended the institution 
of the overlap technique as the primary method of repair, due to significantly fewer 
incontinence symptoms experienced in their patients repaired by the overlap 
technique, as well as a significantly lower incidence of persistent EAS rupture in the 















In our study, 26 (38.2%) cases were repaired by the end-to-end technique and 27 
(39.7%) using the overlap technique. The method of repair in the rest of the cohort 
was not documented in the theatre notes. This is in keeping with trends of surgical 
technique employed that is documented in the literature. The literature further reports 
that 50% of obstetric consultants and 55% of obstetric and gynaecology trainees use 
the overlap technique for repair of OASI (Fernando et al, 2002). 
 
It would appear that the overlap technique was more commonly used in the HIV-
negative patients than the HIV-positive patients (42.6% vs 28.6%), but this difference 
was not statistically significant. Since the numbers of this study are small, and the 
differences in technique employed in the two groups not statistically significant, we 
will not draw conclusion about the tendency seen in the HIV-negative group. This 
study was also not designed for this purpose. 
 
Only two women in this cohort were not prescribed antibiotics. This is not in keeping 
with international standards (Mackenzie et al, 2004; Sultan & Thakar, 2002) or local 
hospital policies. It is not clear whether these were accidental or purposeful 
omissions. Commonly used antibiotics were combinations of Ceftriaxone & 
Metronidazole (43.9%), Amoxycillin & Metronidazole (21.2%), and Ampicillin & 
Metronidazole (16.7%) (Figure 5).  Norderval et al (2005) did not employ routine 
prescription of antibiotics, and noted wound infection in five of the 74 women in their 
study. Three of these women had been prescribed prophylactic antibiotics. Four of the 
five women with wound infections experienced incontinence, and this incontinence 
was considered severe, with Wexner scores >10 in two of them. The authors felt that 
the current evidence does not support routine antibiotic prophylaxis, but that in light 
of the poor outcomes after infection, antibiotic prophylaxis remains a viable proposal. 
The incidence of wound infection at six weeks in our study was 5.6%, and these 
women were both HIV-negative and had received prophylactic antibiotics (Table 7). 
 
The most interesting and unexpected finding in the pre-pregnancy urinary functional 
assessment was that of significantly higher rates of urgency in the HIV-positive 
women (p=0.01). This was not associated with urge incontinence.  
The reason for this difference is not entirely understood, and has not previously been 














counts above 200 (Table 15), and only one of them was on HAART (Table 16). This 
finding may be a confounding error due to the HIV-positive women being 
significantly older than the HIV-negative women at baseline (27 cf 24). It is unclear 
whether this 3 year age disparity alone could account for this difference.  
 
Hermieu et al (1996) investigated a range of micturition disturbances in 39 HIV-
positive patients (predominantly male). Twenty-seven patients had urological 
abnormalities including what they termed hyperactive bladder (63.0%), detrusor 
sphincter dyssynergia and a noncontractile hypoactive bladder, amongst others. A 
neurological diagnosis was identified in 61.5% of the 27 patients (specifically cerebral 
toxoplasmosis and HIV encephalitis).  Voiding disturbances varied in the study, but 
41% of the patients experienced frequency with urgency and incontinence.  They 
conclude that “urgency probably is related to detrusor hyperactivity and can be treated 
adequately by anticholinergic medications” (Hermieu et al, 1996:158).  
It cannot be established whether abnormal neurology is an aetiological factor in our 
patients, as urgency was an isolated symptom in the absence of straining, hesitancy, 
incomplete emptying etc. It would also be expected that if neurology were implicated 
in these patients, the effect would have persisted postpartum. However the lack of this 
finding postpartum may be due to the low follow-up numbers. Acute urinary retention 
has been associated with HIV-seroconversion (Lebovitch and Mydlo 2008).  
 
The antiretroviral drug Indinavir has been associated with urgency and urolithiasis, 
but the majority of our patients experiencing urgency were not on HAART, and none 
on Indinavir (Jaradat et al, 2000; Lebovitch and Mydlo 2008).  
 
It is possible that undiagnosed urinary tract infection (UTI) may have been 
responsible for the urgency in our cohort. Fabian et al (2009) determined that 30% of 
HIV-positive, ART-naïve patients had leukocyturia on urinary dipstix screening. Of 
these patients, 29.1% cultured an infective organism. A potential relationship between 
tuberculosis and sexually transmitted infection with sterile leukocyturia was 
postulated, and the study recommended that urine dispstix screening be employed in 
the care of HIV-positive women. Lebovitch and Mydlo (2008) report UTIs to be most 
common when CD4 count is less than 500, with an incidence of UTI of 17%. They 














involvement. It is remarkable that there is very little other data on the incidence of 
UTI in HIV-infected women.  
 
A Zambian study in 1991 reported a uniformly congested cystoscopic appearance of 
the bladder mucosa in HIV-positive patients with painful urinary frequency, 
suprapubic pain and haematuria. This had not previously been documented. There 
were no associated bladder ulcers and patients had a normal bladder capacity. A non-
specific histological appearance similar to that of interstitial cystitis was seen, except 
that mast cells were absent in all samples (Elem et al, 1991). 
There was no other information in the literature on painful bladder syndrome, 
interstitial cystitis and the overactive bladder syndrome in association with HIV-
infection. Bladder pain was not assessed by our study, and this may be a useful and 
interesting symptom to investigate in a future study. Clearly there remains much work 
to be done in the area of HIV, and its association with UTIs and urinary symptoms.  
 
Urinary incontinence appears to be associated with OASI. In 2008, Scheer et al, 
showed OASI to be an independent risk factor for stress urinary incontinence (SUI) 
and poorer lifestyle impact scores at 10 weeks postpartum in a group of 100 women 
with OASI when compared to a 104 controls. Tetzschner et al (1996) demonstrated 
SUI in 18%, urge urinary incontinence (UUI) in 1%, and mixed incontinence in 13% 
of their subjects between two and four years postpartum. They also demonstrated an 
association between incontinence and a higher degree of perineal injury.  
Wagenius and Laurin (2003) on the other hand, showed no difference in urinary 
continence between women with OASI and controls at four years postpartum. 
Borello-France et al (2006) also did not detect a difference at six weeks and six 
months postpartum in their study of women with OASI and controls. The rate of 
postpartum SUI in our cohort was 8.3%, with significantly more HIV-positive women 
experiencing SUI (p=0.01). Again, this could be accounted for by the HIV-positive 
women being an average of 3 years older, however this difference was not evident at 
baseline, when in fact the number of women assessed (68) was greater. Only 28 
women attended follow-up, and yet this difference was still found to be significant. 
The rate of urgency at follow-up was higher than at baseline (27.8% vs 22.1%), but at 
the postpartum assessment the significant difference between HIV-positive and 














incontinence across the cohort was 16.7%. Baydock et al (2009) showed a rate of 12% 
for UUI and 23% for SUI in follow-up of 632 women without OASI 4 months 
postpartum. The higher rate of pre-pregnancy urgency and post-partum stress 
incontinence amongst HIV-positive women could also be an error as a  result of the 
HIV-positive women in this population being older 
 and mostly confined to one population group, which could have accounted for 
differences between groups. 
We were unable to find any studies on sexual function in low socio-economic, urban 
South African women. Sexual function is a difficult area to study, as it is a field where
anatomy, physiology, psychology, psychiatry, sociology, culture, pathology, religion 
and inter-personal relationships become intricately and inseparably linked. It is widely
acknowledged, however, that there is a paucity of useful data in this field, particularly
using standardised definitions.
The American Foundation for Urologic Disease (AFUD) compiled a multidisciplinary
consensus guideline in 1999 for diagnosing and classifying sexual dysfunction 
(Basson et al, 2000). The 4 broad categories of classification include hypoactive
sexual desire disorders, sexual arousal disorders, orgasmic disorders and sexual pain 
disorders. This classification uses similar categories to those of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV) of the American Psychiatric 
Association, but differs in that the latter concentrated on psychiatric disorders and 
subjective distress, and does not reflect organic pathologies as in the AFUD
classification.
Female sexual dysfunction (FSD) has a reported incidence of 25-63% (Heiman 2002; 
Sidi et al, 2007). In defining dysfunction, it is crucial that the problem causes personal 
distress to the patient. This makes assessing the literature and recognising true 
problems difficult. FSD is more common in women who are younger and less 
frequently sexually active (Laumann et al, 1999; Sidi et al, 2007). However, Sidi et al 
(2007), report higher educational status, a longer marital relationship, 4+ children, and 
an older partner as risk factors for FSD. Laumann et al (1999), on the other hand, 
showed higher education and marriage to be associated with less FSD. Derogatis and 














personal distress of these symptoms decreased. West et al (2004) reported variable 
effects of marriage on FSD. They also comment on the techniques of collecting data 
about sexual dysfunction. FSD was less likely to be reported if the patient was 
interviewed in person, whereas the incidence was higher if a self-administered 
questionnaire was used.  
 
In our study of 68 women, the mean scores on the Abbreviated Sexual Function 
Questionnaire (ASFQ) in the desire domain indicated that the women felt desirous of 
sexual activity, a desire to be touched, having pleasurable sexual thoughts, and 
looking forward to intercourse with scores ranging between 3.0 and 3.2 (equating to 
“sometimes” for all the above domains) in a four week period (Table 6). There was no 
difference between HIV-positive and negative patients. The prevalence of sexual 
desire disorders in the literature, ranges from 20 to 69.6% (Derogatis and Burnett, 
2008; Hayes et al, 2006; Sidi et al, 2007).  Laumann et al (1999), reporting on data 
from the USA 1992 National Health and Social Life Survey, report low levels of 
sexual desire in less educated women, Black women, women of lower socioeconomic 
status (also shown by West et al in 2004) and younger, unmarried women.  
 
Sexual arousal can be present in the absence of sexual desire, and conversely sexual 
desire can be present in the absence of sexual arousal (Basson et al, 2004). Sexual 
arousal can be subjective sexual excitement, or physiological effects such as genital 
lubrication, congestion, and other somatic responses (Basson et al, 2000). The 
prevalence of decreased sexual arousal ranges from 20 to 60.9% (Hayes et al, 2006; 
Sidi et al, 2007; West et al, 2004). Arousal is affected by lower levels of sexual 
activity, and sexual victimisation (Laumann et al, 1999). Of note, the HIV-negative 
women were significantly more likely to experience lubrication - and a greater 
intensity of vaginal pulsating/tingling - during intercourse, than the HIV-positive 
women. The HIV-negative women scored higher in all arousal domains. In the study 
by Sidi et al, amongst Malaysian women in a primary care setting, and the incidence 
of decreased vaginal lubrication was 50.4% (2007). They determined that normally 
lubricated women are 70 times less likely to experience sexual dysfunction than those 















Orgasmic dysfunction has a prevalence of 20-59.1% (Hayes et al, 2006; Sidi et al, 
2007; West et al, 2004), but is only classified as a disorder if it is persistent or 
recurrent, is absent despite high levels of arousal, and causes personal distress 
(Basson et al, 2000). Risk factors for difficulty achieving orgasm include not being 
married, having a lower level of education and a lower socio-economic status 
(Laumann et al, 1999).  
The mean frequency of achieving orgasm in our study was 2.8, which equates to 
“often” (Table 6). Twenty-five percent of women reported achieving orgasm with 
every sexual encounter, and 16% reported never achieving orgasm (Table 6). 
According to the mean AFSQ scores, orgasms were described as being “moderately
pleasurable” when achieved, and that achieving orgasm was “neither easy nor 
difficult” (Table 6). Again, the HIV-negative women had consistently higher scores in 
the orgasm domain, but this difference did not reach statistical significance.
There is a paucity of literature on sexual function in HIV positive women. Luzi et al 
(2009) report a high prevalence of FSD in HIV-positive women, due to self-perceived 
body image changes, specifically abdominal fat accumulation. There was no 
association between FSD and clinical staging, CD4 count, viral load or cumulative
exposure to ART drug classes.
Bell et al (2006) carried out a retrospective survey of FSD amongst HIV-positive 
women attending HIV clinics in the United Kingdom. Half the women reported 
sexual problems or dissatisfaction, and contextual issues appeared to be the
predominant factor. Of note, 60% of HIV physicians appeared to neglect enquiring
about sexual function. 
Given the interplay of psychosocial, circumstantial and likely complicating medical 
factors in a population of HIV-positive women of lower socio-economic status, it is 
likely that FSD may be highly prevalent in our population. Though this was not 
established by the small sample size in this study, it is an area worth investigating 
further.  
In our study, only 5 (13.9%) women had resumed sexual activity at six weeks follow-














of 40% sexual activity at seven weeks postpartum by Andrews et al (2008), where 
degree of perineal injury did not affect resumption of sexual activity; and a rate of 
20% reported by Signorello et al (2001) at six weeks postpartum.  
 
In a study by Macarthur and Macarthur (2004), 20% of women with OASI reported 
perineal pain at six weeks, compared to 13% of women with episiotomies, and 4% of 
those who had had a first or second degree tear. The relative risk of pain at six weeks 
after OASI was 5.2 (95% CI 0.6-32.1). 
The mean postpartum pain scores in our study population, per 10-point visual 
analogue scale were 0.4, 0.5 and 0.1 for walking, sitting and at rest, respectively 
(Table 10). There were no significant differences between the HIV-positive and 
negative women. Andrews et al (2008) reported mean scores of 1.04, 0.63 and 0.58 on 
an 11-point visual analogue scale for pain on movement, sitting and at rest for women 
with a 3a OASI, and scores of 1.23, 1.53 and 1.12 respectively for the women with 
3b, 3c or 4th degree OASIs, at seven weeks postpartum. 
Perineal pain was elicited to touch on clinical examination in 16 (44.4%) of our 36 
women, five (62.5%) of whom were HIV-positive and 11 (39.3%) HIV-negative 
(Table 7). This difference was not statistically significant. 
 
A clinically detectable partial anal sphincter defect was found in nine (25%) and a 
complete sphincter defect in none of the women in our cohort. There was no 




The study was a predominantly clinical study, since resource constraints prevented objective 
measurements such as endoanal ultrasonography and manometry. Thus the study relied heavily 
on questionnaires as measurement tools. This could have introduced measurement bias, though 
the design of the study attempted to be minimise this. Patients completing the questionnaire 
could have made errors in recall of their pre-pregnancy functional status. The tools used could 
have been inadequately sensitive measures, though to prevent this we used validated tools 
elsewhere described and used. Patients were spoken to in private and every attempt was made 
to minimise any embarrassment they might feel in reporting their functional status, as the 














principal investigators who conducted the questionnaires and follow-up clinical examinations 
could have been subject to expectation bias, as the study was not blinded. Another limitation 
was the omission of gathering data on any previous pelvic floor muscle training, or perineal 
injury other than OASI.  
 
The study was designed to enrol all eligible women with an OASI. Analysis revealed that the 2 
groups, HIV-positive and HIV-negative, had significant differences in age and race. This could 
have contributed to differences elicited in outcomes, as the study was not designed to match or 
pair study participants. This could have resulted in selection bias which also limits 
interpretation of results.   
 
The use of questionnaires and predefined tools makes the study easily reproducible. 
Generalisability of results remains to be confirmed however, as this study lacked sufficient 
power and is the first and only study to look at the issue of OASI in relation to HIV-infection.  
 
The study is underpowered due to inability to enrol sufficient patients in the enrolment period. 
Added to this is the massive loss to follow-up of 47%. Although loss to follow-up is elsewhere 
documented in the literature, this sadly added to the limitation in the interpretation of our 
results in a study of already small numbers. Due to the lack of power, the results of the study 



























Chapter 5:  Conclusion 
 
This study provides useful data on a population on which there is almost no 
information in the literature. We report on baseline (pre-pregnancy) assessment of 
female sexual function, urinary function, perineal pain and anal continence in urban, 
younger, predominantly non-White South African women. Prior to this study, there 
was no data on the impact of HIV-infection on OASI and perineal pain, and very little 
on the relationship of HIV to urinary symptoms and sexual dysfunction. 
 
Despite the small sample size, large loss to follow-up and resultant lack of power of 
the study, we made some interesting findings. With further recruitment more 
significant findings may yet be elicited, hopefully with sufficient power to be 
clinically relevant. 
 
From our study, it is suggested that anal continence is impaired after OASI in HIV-
positive women. HIV-positive women had higher mean Wexner scores in each 
domain, and higher relative risks for all domains. Unfortunately the differences failed 
to reach statistical significance. These findings were despite the absence of infection 
at six weeks and may be related to HIV being a chronic disease affecting tissues and 
healing. No relationship with CD4 count or Anti-retroviral Therapy was elicited in 
this study. 
 
Interesting and not completely understood findings were found in the assessment of 
pre and post-partum urinary function. HIV-positive women had significantly more 
pre-pregnancy urgency, a finding not previously documented. Though this did not 
persist postpartum, it may with further recruitment and a larger sample size at follow-
up. Also of interest was the significantly higher incidence of stress incontinence in the 
HIV-positive women postpartum. This could be an error due to baseline age and race 
differences in the groups, but it could also be a real difference – possibly related to 
urinary tract infection, poorer healing in general, or possibly an effect of HIV on the 















Sexual function data for our population is valuable in that it draws attention to a 
grossly neglected area of study for our patients. Though more attention is given to 
female sexual function in the international data, there remains little for women in 
developing countries, and none for HIV-positive women in developing countries. This 
study showed interesting trends for sexual function. The HIV-negative women scored 
higher for all domains except desire and frequency of intercourse. The increased 
frequency of intercourse could have been instrumental in the cause of the HIV-
infection. Two arousal domains did reach significance between the groups, namely 
frequency of vaginal lubrication during intercourse and quantity of vaginal 
pulsating/tingling. Both of these domains were higher in the HIV-negative women. 
These findings all point to a need for further investigation into the sexual functioning 
of HIV-positive women, with more in-depth quantitative analyses to elicit the exact 
extent and origins of any dysfunctions.  
 
Perineal pain is a common and often ignored area that affects not only women with 
OASI, but to a degree, all women who deliver vaginally. Pain scores between our two 
groups were similar - and reassuringly - low, at six weeks postpartum. 
 
This study is the first in its field, and despite small numbers has already yielded 
significant, interesting, and concerning findings. We recommend further and ongoing 
investigation into the impact of HIV on OASI, as well as urinary and sexual 
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Healing and Functional Outcomes after Obstetric Anal Sphincter Injury in HIV-
positive vs HIV-negative patients 
 
Principal Investigators: Dr Julie van den Berg 
   Dr Stephen Jeffery 
   Department of Obstetrics & Gynaecology 
   Faculty of Health Sciences 
   Anzio Road 
   Observatory 
   7925 
   Tel 082 572 8686  Email julievdberg@yahoo.com 
 
 I, ___________________________________________(name of participant/legal 
guardian), hereby agree to participate in the above study conducted between 
Groote Schuur, Mowbray Maternity, and New Somerset Hospitals. 
 I have read the attached Patient Information Sheet and this Consent Form, and 
have had the opportunity to ask questions about the study. 
 I consent to disclose my HIV status to the study investigators, as well as any 
other relevant medical information from my medical records that is of 
relevance to the study.  
 I understand that the study entails personal and private questions, as well as a 
physical vaginal and rectal examination. 
 I agree to my responses being used for medical education and research on the 
condition that my privacy is respected and anonymity ensured so that I will 
not be personally identified in/by the study. 
 I understand that I am under no obligation to participate in the study. 
 I understand that the study will be in two phases approximately 6 weeks apart, 
and that I have the right to withdraw from the study at any time. 
 I understand that I will be reimbursed a fixed, prearranged amount for 
transport costs incurred by the study only, and receive no other renumeration 
for participation in the study. 
 
Signature of Participant:    _________________________________ 
 
Name of person obtaining consent:    _________________________________ 
Signature of person obtaining consent: __________________________________ 
 
Name of Witness:   __________________________________ 
Signature of Witness:   __________________________________ 
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Toestemmings Vorm  
Studie op 
Gesondheid en Werking van die Anus na ‘n Skeur tydens Geboorte 
in MIV-positiewe en MIV-negatiewe pasiënte 
 
Ondersoekers: Dr Julie van den Berg 
  Dr Stephen Jeffery 
  Department of Obstetrics & Gynaecology 
  Faculty of Health Sciences 
  Anzio Road 
  Observatory 
  7925 
  Tel 082 572 8685 Epos julievdberg@yahoo.com 
 
 Ek,_________________________(naam van pasiënt/wettige voog), stem 
hiertoe in tot deelname aan bogenoemde studie wat gedoen sal word by Groote 
Schuur, Mowbray Maternity en Somerset Hospitale. 
 Ek het die aangehegde Ingligting Stuk gelees en hierdie Toestemmings Vorm, 
en het die geleentheid gehad om vrae te vra oor die studie. 
 Ek gee toestemming dat my MIV status bekend gemaak mag word aan die 
ondersoekers, sowel as ander relevante mediese en privaat vrae, sowel as 
vaginale en anale ondersoeke. 
 Ek stem toe dat die inligting wat ek gee gebruik gaan word vir mediese 
onderrig en navorsing op voorwaarde dat my reg op privaatheid gerespekteer 
word en date k anoniem sal bly tydens die studie. 
 Ek verstaan dat ek onder geen verpligting is om deel to neem aan die studie 
nie 
 Ek verstaan dat die studie in twee fases geskied, ongeveer 6 weke uit mekaar 
en date k die reg het om te enige tyd te onttrek. 
 Ek verstaan date k vergoeding sal kry teen ‘n vasgestelde vooraf bepaalde 
koste vir vervoer slegs vir die doeleindes van die studie en date k geen ander 
vergoeding sal ontvang vir deelname aan die studie nie. 
 
Handtekening van deelnemer:_________________________________________ 
 
Naam van persoon wat toestemming kry:________________________________ 
Handtekening:_____________________________________________________ 
 





















Appendix 2 Patient Information Sheet 
1. Why have I been invited to participate in this study?
You have been asked to participate in this study because you have had an anal sphincter injury
during your vaginal delivery.
2. What is an obstetric anal sphincter injury?
An obstetric anal sphincter injury is often called a third or fourth degree tear. This means that
during vaginal delivery a tear occurs that reaches from the vagina to the anus. The muscle around
the anus, that usually keeps the anus closed, is torn.
3. What are the consequences of an anal sphincter injury?
If the muscles of the anal sphincter are not repaired by stitching them back together, there is a high
risk that the anal sphincter will not work properly, and this can result in leakage of flatus(wind)
and stool(faeces). This is why an anal sphincter injury is always repaired surgically. Even after a
surgical repair, there is a risk that some women will experience the problems of leakage of flatus
and stool. Other problems can include leakage or urine, pain, and pain on sexual intercourse.
4. Why does my HIV status need to be known?
This study is investigating whether or not being HIV positive causes delayed healing and more 
problems, after repairing the muscles around the anus.
5. Who will have access to the information I give?
Only the doctors involved in the study will have access to the information provided on the 
questionnaire. Patient participation is completely anonymous. Once the study is finished, the 
results will be written up in a thesis, presented to other doctors, and possibly be published in a 
medical journal.
6. What will happen if I don’t enter the study?
Nothing. Patients not joining in the study will still be followed up at Groote Schuur Hospital to
make sure that they do not have any complications.
7. What will happen if I have problems after I leave the hospital?
Patients can either attend the follow-up clinic at Groote Schuur Hospital on the day they are given
an appointment, or attend any Emergency Casualty Department or Day Hospital if they need care 
before that time.
8. What will I gain from being in the study?
Joining in the study will not give you any extra medical care or information that is not available to
all patients. However, patients in the study will be reimbursed for transport costs to attend the 
follow-up appointment.
9. What are the risks to being in the study?
There are no real risks to being enrolled in the study.
10. What is expected from me in the study?
All that is expected from you in the study is your consent for us to access confidential information
from your medical records, to answer a questionnaire at enrolment, and to complete another
questionnaire as well as undergo a vaginal and rectal examination at the 6-week follow-up visit.
11. How long is my involvement in the study?
Involvement in the study only involves the data collected in hospital, and at the 6 week follow-up
visit. Any extra hospital visits or follow-up will be as a normal patient and not as part of the study.
12. Can I change my mind about the study?














Pasiënt Inligting Bladsy 
 
1. Hoekom is ek uitgenooi om deel to neem aan hierdie studie? 
Jy is uitgenooi on deel to neem aan die studie ondat jy ‘n anale skeuring gehad het tydens 
normale geboorte. 
 
2. Wat is ‘n anale skeuring tydens geboorte? 
‘n Anale skeuring word dikwels ‘n derde of vierde graadse skeur genome. Dit beteken dat 
tydens geboorte ‘n skeur ontwikkel vanaf die vagina tot by die anus. Skeuring van die 
spier wat gewoonlik die anus toe hou vind plaas. 
 
3. Wat is die gevolge van ‘n anale skeuring? 
Indien die anal espier nie met steke geheg word nie, is die risiko groot dat die anale spier 
nie korek sal funksioneer nie. Dit kan veroorsaak dat winde en stoelgang kan voorkom. 
Om die rede word ‘n anale skeuring altyd chirurgiese herstel. Selfs na chirurgie kan 
sommige vrouens nog steeds lekking ondervind. Ander probleme sluit in urinale druip, 
pyn en pyn tydens omgang. 
 
4. Hoekom moet ek my MIV status bekend maak? 
Die studie prober bepaal of daar ‘n noemenswaardige verskil is by die hersteltye en 
komplikasies tydens en na anale skeuring tussen MIV-positiewe en negatiewe persone. 
 
5. Wie sal toegang hê tot die inligting wat ek verskaf? 
Slegs die dokters wat betrokke is by die studies sal toegang tot u inligting verkry. Die 
pasiënt se deelname is anoniem. Die resultat sal in ‘n tesis gebruik word, voorgelê word 
aan ander dokters, en moontlik in ‘n mediese joernal gepubliseer word. 
 
6. Wat sal gebeur as ek nie deelneem aan die studie nie? 
Niks. Pasiënte wat nie deelneem nie sal voortgaan op die normale behandeling van die 
skeur. 
 
7. Wat gebeur indien komplikasies ontstaan nadat ek die hospitaal verlaat het? 
Pasiënte kan die Opvolgkliniek besoek soos vir hulle gereël is, of hulle kan by die 
Ongevalle aanmeld, of die Daghospitaal besoek as hulle hulp nodig het voor hul afspraak. 
 
8. Watter voordele is daar vir my tydens die studie? 
Deelname aan die studie gee u nie bykomende toegang tot mediese sorg of inligting wat 
nie aan ander pasiënte beskikbaar is nie. Pasiënte sal wel verged word vir vervoer kostes 
om aan opvolgbesoeke deel te neem. 
 
9. Is daar enige risiko’s vir my verbonde aan die studie? 
Daar is geen bykomende risiko’s betrokke by die studie nie. 
 
10. Hoe lank sale k betrokke wees by die studie? 
Deelname aan die studie sluit slegs in die inligting wat by die hospitaal geneem word en 
tydens die 6 weke opvolg besoek. Enige ander besoeke of opvolg ondersoeke is vir die 
pasiënt en vorm nie deel van studie nie. 
 
11. Kan ek te enige tyd onttrek aan die studie? 
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Appendix 3 continued   Page 2 of 6 
  
Patient Folder Number    Study Number 
 
Date       Pt Phone No:  _______________ 
          
Part 1: Data obtained from folder and/or patient 
 
HIV Status     1=Positive  2=Negative  
 
 
If HIV positive, CD4 count   1= <200 2= 200-500 3= >500 
 
Absolute Value      
 
  
Antiretrovirals     1= PMTCT 2= HAART 3= Nil 
 
If HAART, please specify   ____________________ 
 
 
Injury sustained    1= 3rd Degree Tear (3a) 
      2= 3rd Degree Tear (3b)  
      3= 3rd Degree Tear (3c) 
      4= 4th Degree Tear 
      5=Detail not specified 
 
Technique of Repair    1= End-to-end   2= Overlap  3=Unknown    
 
Suture Type for anal mucosa   ___________________ 
Suture Type for IAS    ____________________ 
Suture Type for EAS    ____________________ 
Suture for deep subcutaneous tissue  ____________________ 
Suture type for vagina    ____________________ 
Suture type for perineum   ____________________ 
 
 
Post-operative antibiotics   1= Yes  2=No 
 
Specify antibiotics    ____________________ 
 
 
Age      
 
 
Ethnic Group     1= Black 2= Coloured  
3= White 4= Other _____________  
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Study Number 
 
Part 2: Data to be obtained from patient 
 





Anal continence (please circle) 
 
The Wexner Score 












Solid 0 1 2 3 4 
Liquid 0 1 2 3 4 
Gas 0 1 2 3 4 
Wears pad 0 1 2 3 4 
Lifestyle alteration 0 1 2 3 4 
0   = perfect continence 






Perineal Pain  (please circle; 0=never; 10=worst imaginable) 
 
Have you ever experienced pain of the perineum on walking?       
0     1      2      3      4      5      6      7    8      9     10  
 
Have you ever experienced pain of the perineum on sitting?  
0     1      2      3      4      5      6      7    8      9     10  
       
Have you ever experienced pain of the perineum on driving? 
0     1      2      3      4      5      6      7    8      9     10  
    
Have you ever experienced pain of the perineum at rest? 
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1. Daily Frequency (number of voids) 
 
   
 




3. Urgency      
 
  1=Yes      2=No  
 
4. Urge Incontinence   
 
  1=Yes       2=No 
Frequency of urge incontinence (please circle) 
     < 1x per week  2-3 x  a week  Daily  All Day   
  
0 1 2 3 4 5 6 7 8 9        10 
 
5. Stress Incontinence   
 
  1=Yes      2=No  
Frequency of stress incontinence (please circle) 
     < 1x per week  2-3 x  a week  Daily  All Day   
  
0 1 2 3 4 5 6 7 8 9         10 
 
6. Voiding Symptoms  
Straining   
 
  1=Yes       2=No 
Double Voiding  
 
  1=Yes       2=No 
Poor Stream    
 
  1=Yes       2=No 
Post Micturition Dribbling 
 
  1=Yes       2=No 
Hesitancy   
 
  1=Yes       2=No 
Incomplete Emptying  
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1. Over the last 4 weeks, how often have you had pleasurable thoughts and 
feelings about sexual activity? 
Not at all (1)   Rarely (2)   Sometimes (3)     Often (4)        Very often (5) 
 
2. Over the last 4 weeks, how often have you wanted to be sensually touched or   
caressed by your partner?        
Not at all (1)   Rarely (2)   Sometimes (3)     Often (4)        Very often (5) 
 
3. Over the last 4 weeks, how often have you wanted to take part in sexual 
activity? 
Not at all (1)         Rarely (2) Sometimes (3)      Often (4)      Very often (5) 
 
4. Over the last 4 weeks, how often have you initiated sexual activity with your    
partner? 
Not at all (1)         Rarely (2) Sometimes (3)      Often (4)      Very often (5) 
 
5. Over the last 4 weeks, how often did you take part in sexual activity with 
penetration (eg vaginal penetration and intercourse)? 
Nil (0)            1-2 times (1) 3-4 times (2)      5-8 times (3)     9-12 times (4) 
13-16 times (5)  >16 times (6)  
  
6. Thinking of your sexual life over the last 4 weeks, how often did you look 
forward to sexual activity?  
Not at all (1)         Rarely (2) Sometimes (3)      Often (4)      Very often (5) 
 
7. Over the last 4 weeks, how often did you have a feeling of “warmth” in your 
vagina/genital area when you took part in sexual activity? 
I did not take part in sexual activity (-)  Not at all (1)                 Sometimes (2)  
Often (3)      Very often (4)  Every time (5)  
 
8. Over the last 4 weeks, in general, how much “warmth” did you feel in your 
vagina/genital area when you took part in sexual activity? 
I did not take part in sexual activity (-) None (1) Slightly warm (2)  
Moderately warm (3)  Very warm (4) Extremely warm (5) 
 
9. Over the last 4 weeks, how often did you have a sensation of “pulsating” 
(“tingling”) in your vagina/genital area when you took part in sexual 
activity? 
I did not take part in sexual activity (-)  Not at all (1)                 Sometimes (2)  
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10. Over the last 4 weeks, in general, how much “pulsating” (“tingling”) did you 
notice in your vagina/genital area when you took part in sexual activity? 
I did not take part in sexual activity (-) No sensation (1)      A mild sensation (2) 
A moderate sensation (3)  A strong sensation (4)           A very strong sensation (5) 
 
11.  Over the last 4 weeks, in general, how often did you notice vaginal 
wetness/lubrication when you took part in sexual activity? 
I did not take part in sexual activity (-)  Not at all (1)                 Sometimes (2)  
Often (3)      Very often (4)  Every time (5)  
 
12. Over the last 4 weeks, in general, how much vaginal wetness/lubrication did 
you notice when you took part in sexual activity? 
I did not take part in sexual activity (-) No wetness/lubrication (1)  
Slightly wet/lubricated (2)  Moderately wet/lubricated (3) 
Very wet/lubricated (4)   Extremely wet/lubricated (5) 
 
13. Over the last 4 weeks, how often did you have an orgasm when you took part 
in sexual activity (may be with or without a partner)? 
I did not take part in sexual activity (-) Not at all (1)  Sometimes (2) 
Often (3)     Very often (4)  Every time (5) 
 
14. Over the last 4 weeks, in general, how pleasurable were the orgasms that you 
had? 
I did not take part in sexual activity(-)   Not pleasurable(1)  Slightly pleasurable(2) 
Moderately pleasurable (3)        Very pleasurable (4)      Extremely pleasurable (5)  
 
15. Over the last 4 weeks, in general, how easy was it for you to reach orgasm? 
I did not have orgasms (0) Very difficult (1) Quite difficult (2) 





























Appendix 3  (Part 2 Data Collection Sheet as for Part 1 Data Collection Sheet less 
demographic data plus postpartum examination data) 
 
           
       Study Number 
 
Part 2: Examination 
 
1. Wound completely healed?    1= Yes  2= No 
 
2. Evidence of current infection?    1= Yes  2= No 
 
3. Dehiscence?     1= Nil  2=Partial
    3= Complete 
 
 
4. Granuloma?      1= Yes  2= No 
 
5. Anal Sphincter Tone on pr examination   1= Normal    2=Decreased 
 
 
6. Anal sphincter integrity on pr examination  1= Completely intact 
        2= Partial defect 
        3= Complete defect 
 
7. Oxford score for vaginal contraction (please circle score) 
 
   Score Findings 
   0  Nil 
   1  Flicker of muscle contraction 
   2  Weak contraction 
   3  Medium: slight lift of examiner’s finger, no resistance 
   4  Strong: elevation of examiner’s finger against light resistance 
   5  Very strong: elevation of examiner’s finger against strong resistance 
 
 
8. Perineal pain        1= Yes  2= No 
(please circle area of pain) 
 
         12 
         11                   1 
    
          10                                      2 
      
9                                           3 
 
  8                                       4 
 
     7                       5 
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